✦ LIBER ✦

Colistimethate Sodium Dry Powder for Inhalation: A Review of Its Use in the Treatment of ChronicPseudomonas aeruginosaInfection in Patients with Cystic Fibrosis

✍ Scribed by Conole, Daniel; Keating, Gillian M.

Book ID: 121508153
Publisher: Springer International Publishing AG
Year: 2014
Tongue: English
Weight: 441 KB
Volume: 74
Category: Article
ISSN: 0012-6667
DOI: 10.1007/s40265-014-0181-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systematic review of the dry powder inha

Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis

✍ Uttley, L.; Harnan, S.; Cantrell, A.; Taylor, C.; Walshaw, M.; Brownlee, K.; Tap 📂 Article 📅 2013 🏛 European Respiratory Society 🌐 English ⚖ 427 KB

This systematic review evaluated evidence for two dry powder formulations, colistimethate sodium and tobramycin, for the treatment of chronic __Pseudomonas aeruginosa__ in cystic fibrosis, as part of the UK national recommendation process for new technologies. Electronic bibliographic databases were

Tobramycin Inhalation Powder: A Review o

Tobramycin Inhalation Powder: A Review of Its Use in the Treatment of ChronicPseudomonas

✍ McKeage, Kate 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 556 KB

309 Piloting the use of the cystic fibro

309 Piloting the use of the cystic fibrosis questionnaire (CFQ) in CF patients changing to dry powder inhaled colistimethate

✍ S.P. Conway; J.C. Davies; C. Etherington; M.H. Goldman; E. Howard; A. Jaffe; N.K 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Systematic Review of Colistimethate Sodi

Systematic Review of Colistimethate Sodium Dry Powder and Tobramycin Dry Powder Antibiotics for Pseudomonas Aeruginosa Lung Infection in Cystic Fibrosis

✍ Harnan, S.E.; Uttley, L.; Cantrell, A.; Taylor, C.J.; Walshaw, M.; Brownlee, K.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

The Cost-Effectiveness of Dry Powder Ant

The Cost-Effectiveness of Dry Powder Antibiotics for the Treatment of Pseudomonas Aeruginosa in Patients with Cystic Fibrosis

✍ Tappenden, P.; Harnan, S.; Uttley, L.; Mildred, M.; Taylor, C.J.; Brownlee, K.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Tolerability and Pharmacokinetic Propert

Tolerability and Pharmacokinetic Properties of Ciprofloxacin Dry Powder for Inhalation in Patients With Cystic Fibrosis: A Phase I, Randomized, Dose-Escalation Study

✍ Stass, Heino; Weimann, Boris; Nagelschmitz, Johannes; Rolinck-Werninghaus, Claud 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 276 KB